Division of Anti-tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Zhang Jiang Hi-Tech Park, Shanghai 201203, People's Republic of China.
J Mol Med (Berl). 2012 Aug;90(8):971-81. doi: 10.1007/s00109-012-0865-4. Epub 2012 Mar 10.
We have recently discovered that c-Jun executes a non-transcriptional function to stabilize hypoxia inducible factor 1α (HIF-1α) and that pseudolaric acid B (PAB) accelerates HIF-1α degradation and phosphorylates c-Jun at Ser63/73. In this study, PAB was used as a probe to investigate whether and how the Ser63/73 phosphorylation of c-Jun regulates its functions. The PAB-induced reduction of HIF-1α protein was rescued through supplying additional non-phosphorylated c-Jun. However, c-Jun siRNA, which reduced both the PAB-driven phosphorylated c-Jun and the total c-Jun protein, did not prevent the PAB-induced decrease in HIF-1α. HIF-1α was revealed to be co-immunoprecipitated only with the non-phosphorylated c-Jun. PAB increased the phosphorylated c-Jun while reducing the non-phosphorylated c-Jun at Ser63/73, which impaired its function in stabilizing HIF-1α. Consequently, PAB led to the degradation of HIF-1α, thus resulting in the decreased HIF-1α-dependent expression of mdr-1 and VEGF. We accordingly propose a function-converter model of c-Jun: the Ser63/73 phosphorylation serves as a function converter to convert c-Jun from its non-transcriptional function to its transcriptional function.
我们最近发现 c-Jun 执行非转录功能以稳定缺氧诱导因子 1α(HIF-1α),而 pseudolaric acid B(PAB)加速 HIF-1α降解并使 c-Jun 在 Ser63/73 磷酸化。在这项研究中,PAB 被用作探针来研究 c-Jun 的 Ser63/73 磷酸化是否以及如何调节其功能。通过提供额外的非磷酸化 c-Jun,PAB 诱导的 HIF-1α 蛋白减少得到了挽救。然而,c-Jun siRNA 降低了 PAB 驱动的磷酸化 c-Jun 和总 c-Jun 蛋白,但不能阻止 PAB 诱导的 HIF-1α 减少。仅发现 HIF-1α 与非磷酸化的 c-Jun 共免疫沉淀。PAB 增加了磷酸化的 c-Jun,同时减少了 Ser63/73 处的非磷酸化 c-Jun,从而损害了其稳定 HIF-1α 的功能。因此,PAB 导致 HIF-1α 的降解,从而导致 HIF-1α 依赖性 mdr-1 和 VEGF 的表达减少。因此,我们提出了 c-Jun 的功能转换器模型:Ser63/73 磷酸化作为功能转换器,将 c-Jun 从非转录功能转换为转录功能。